Glossary
Laterin S Jan
FDA Investigator Details
Laterin S Jan
Visit Investigator ProfileInvestigation Details
Last Issued Date
July 15, 2016
Conversion Rate
0
% Conversion
No. of 483’s Issued
1
Warning Letters Issued
0
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Investigator Jan is methodical and precise, prioritizing stringent adherence to FDA guidelines, especially those around drug labeling. It appears that he meticulously reviews all components of a product label for compliance with stipulated FDA requirements.
Profile:
Investigator Laterin S Jan appears to have a keen eye for detail, especially when it comes to labeling regulations as per the FDA's compliance guidelines. His focus predominantly lies on the accuracy and completeness of drug product labels.
Top Process Types:
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now